Determinants for Predicting Serious Adverse Event (SAE) Rates Across Study Duration in Selected CNS Indications.

Time

Tue, Mar 05 8:30AM
8

Title

Determinants for Predicting Serious Adverse Event (SAE) Rates Across Study Duration in Selected CNS Indications.

Abstract Summary

Using an Illustrative data set, three CNS indications, Depression, Alzheimer’s and Parkinson’s disease, were selected for review. Numbers of patients randomized were compared to SAE numbers for study duration. Final SAE numbers for completed trials are publicly available at clinicaltrials.gov.

Poster Presenter

Weng Lee
Medical Director,
Quintiles
Ireland

© 2015 DIA